QUN08812

• CAT Number: I035361
• CAS Number: 6308-81-2
• Molecular Formula: C12H20ClNO3
• Molecular Weight: 261.75
• Purity: 98%
• Synonyms: QUN08812; QUN 08812; QUN-08812; N-methyl Mescaline hydrochloride; N-methyl Mescaline HCl; N-methyl TMPEA
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-methyl-2-(3,4,5-trimethoxyphenyl)ethan-1-amine hydrochloride
• InChI: InChI=1S/C12H19NO3.ClH/c1-13-6-5-9-7-10(14-2)12(16-4)11(8-9)15-3;/h7-8,13H,5-6H2,1-4H3;1H
• InChIKey: QHBQZCHOXCFQGY-UHFFFAOYSA-N
• SMILES: COC1=CC(CCNC)=CC(OC)=C1OC.Cl

QUN08812(CAT: I035361) is a novel and potent inhibitor of glycogen synthase kinase-3 (GSK-3), widely utilized in neurodegenerative disease and oncology research. By selectively targeting GSK-3, it modulates key signaling pathways involved in cell survival, apoptosis, and metabolic regulation. QUN08812 is particularly valuable for investigating therapeutic strategies for conditions such as Alzheimer’s disease, Parkinson’s disease, and certain cancers where dysregulated GSK-3 activity plays a critical role. Its high potency and specificity make it an essential tool for preclinical studies aiming to advance the understanding of GSK-3-mediated mechanisms and develop targeted therapies for related diseases.